Bryan W. Chen

79 Qingchun Rd
Hangzhou, 310003, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Reappraising the role of angiography in managing intraluminal postpancreatoduodenectomy hemorrhage: Analysis of 115 cases from 3,011 consecutive pancreatoduodenectomies.

Reappraising the role of angiography in managing intraluminal postpancreatoduodenectomy hemorrhage: Analysis of 115 cases from 3,011 consecutive pancreatoduodenectomies.

Journal: Surgery

Published: January 11, 2026

WZ4003 sensitizes hepatocellular carcinoma to OSI-027 by inhibiting ARK5-mediated autophagy.

WZ4003 sensitizes hepatocellular carcinoma to OSI-027 by inhibiting ARK5-mediated autophagy.

Journal: Cancer letters

Published: January 18, 2025

The role of adjuvant transcatheter arterial chemoembolization following repeated curative resection/ablation for hepatocellular carcinoma with early recurrence: a propensity score matching analysis.

The role of adjuvant transcatheter arterial chemoembolization following repeated curative resection/ablation for hepatocellular carcinoma with early recurrence: a propensity score matching analysis.

Journal: BMC cancer

Published: January 30, 2024

Decreased expression of H19/miR-675 ameliorates hypoxia-induced oxaliplatin resistance in colorectal cancer.

Decreased expression of H19/miR-675 ameliorates hypoxia-induced oxaliplatin resistance in colorectal cancer.

Journal: Heliyon

Published: November 02, 2023

Carcinosarcoma of the pancreas: comprehensive clinicopathological and molecular characterization.

Carcinosarcoma of the pancreas: comprehensive clinicopathological and molecular characterization.

Journal: HPB : the official journal of the International Hepato Pancreato Biliary Association

Published: December 03, 2019

lncRNA-POIR promotes epithelial-mesenchymal transition and suppresses sorafenib sensitivity simultaneously in hepatocellular carcinoma by sponging miR-182-5p.

lncRNA-POIR promotes epithelial-mesenchymal transition and suppresses sorafenib sensitivity simultaneously in hepatocellular carcinoma by sponging miR-182-5p.

Journal: Journal of cellular biochemistry

Published: September 11, 2019

G protein-coupled estrogen receptor deficiency accelerates liver tumorigenesis by enhancing inflammation and fibrosis.

G protein-coupled estrogen receptor deficiency accelerates liver tumorigenesis by enhancing inflammation and fibrosis.

Journal: Cancer letters

Published: June 14, 2016

ARK5 promotes doxorubicin resistance in hepatocellular carcinoma via epithelial-mesenchymal transition.

ARK5 promotes doxorubicin resistance in hepatocellular carcinoma via epithelial-mesenchymal transition.

Journal: Cancer letters

Published: February 11, 2016

OSI-027 inhibits pancreatic ductal adenocarcinoma cell proliferation and enhances the therapeutic effect of gemcitabine both in vitro and in vivo.

OSI-027 inhibits pancreatic ductal adenocarcinoma cell proliferation and enhances the therapeutic effect of gemcitabine both in vitro and in vivo.

Journal: Oncotarget

Published: April 06, 2015

Inhibition of mTORC2 Induces Cell-Cycle Arrest and Enhances the Cytotoxicity of Doxorubicin by Suppressing MDR1 Expression in HCC Cells.

Inhibition of mTORC2 Induces Cell-Cycle Arrest and Enhances the Cytotoxicity of Doxorubicin by Suppressing MDR1 Expression in HCC Cells.

Journal: Molecular cancer therapeutics

Published: January 29, 2015

WP1130 increases doxorubicin sensitivity in hepatocellular carcinoma cells through usp9x-dependent p53 degradation.

WP1130 increases doxorubicin sensitivity in hepatocellular carcinoma cells through usp9x-dependent p53 degradation.

Journal: Cancer letters

Published: January 10, 2015

Showing 1-11 of 11

Last Updated: 09/26/2026